Status:
UNKNOWN
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This prospective single-center study evaluates a current care procedure. It includes 14 patients diagnosed with SSc according to the ACR/EULAR criteria or the Leroy \& Medsger criteria of the disease....
Eligibility Criteria
Inclusion
- Patients older than 18 or younger than 80 years.
- Suffering from systemic scleroderma.
- Patient follow-AP-HM.
- Score of 20 or greater MHISS.
- Score Rodnan level greater than or equal to one face.
- Mouth opening (inter-incisor distance) \<5.5 cm
- Wishing to receive surgery at the face.
Exclusion
- Less than 18 or greater than 80 age.
- Decaying history of abdominal surgery.
- Body mass index lower than 18.
- Coagulation disorders.
- Allergy to Xylocaine.
- Greater than 20mg / d steroids.
- Severe infection.
- Inmates.
- Pregnant women.
- Adults protected by law (under guardianship and trusteeship).
- No affiliation to a social security scheme.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02206672
Start Date
July 1 2014
End Date
November 1 2015
Last Update
November 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13354